Date | Goodwill | Total Assets | Current Liabilities | Total Non-Current Liabilities |
---|
CEO | Mr. Hemanth Damodar Pathak |
IPO Date | Aug. 22, 2017 |
Location | India |
Headquarters | 706 to 709, Aravalli Business Center |
Employees | 27 |
Sector | Healthcare |
Industries |
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.
Past 5 years
USD 1.15
USD 10.92
USD 13.52
USD 0.64
StockViz Staff
February 2, 2025
Any question? Send us an email